Effect of fluvoxamine on 5-hydroxytryptamine uptake, paroxetine binding sites and ketanserin binding sites in the Japanese monkey brain and platelets, in vivo and in vitro

Shinichiro Goto, Toru Egashira, Yuji Wada, Fusako Takayama, Yasumitsu Yamanaka

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

We investigated the in vitro effects of fluvoxamine on 3H-paroxetine binding and 3H-monoamine uptake in monkey cerebral cortex in comparison with those of other antidepressants. Fluvoxamine selectively inhibited 3H-5-hydroxytryptamine (5-HT) uptake and 3H-paroxetine binding. However, it did not alter 3H-norepinephrine or 3H-dopamine uptake. In addition, we examined the effects of chronic treatment with fluvoxamine (5 mg/kg per day, p.o.) on 5-HT uptake sites that bind 3H-paroxetine and 5-HT2 receptors that bind 3H-ketanserin, in monkey brains and platelets. Chronic treatment with fluvoxamine affected neither the paroxetine binding sites nor the kentanserin binding sites of the brains and platelets. These results suggest that long-term treatment with fluvoxamine does not affect either the 5-HT uptake sites or 5-HT2-receptors of 5-HT neurons in monkey brain in spite of its strong inhibitory effect on 5-HT uptake in vitro.

Original languageEnglish
Pages (from-to)291-298
Number of pages8
JournalJapanese Journal of Pharmacology
Volume71
Issue number4
Publication statusPublished - 1996
Externally publishedYes

Fingerprint

Fluvoxamine
Ketanserin
Paroxetine
Macaca
Serotonin
Blood Platelets
Binding Sites
Brain
Haplorhini
Cerebral Cortex
Antidepressive Agents
Dopamine
Norepinephrine
In Vitro Techniques
Neurons

Keywords

  • 5-Hydroxytryptamine uptake
  • Fluvoxamine
  • Monkey brain
  • Monkey platelet
  • Paroxetine binding

ASJC Scopus subject areas

  • Pharmacology
  • Molecular Medicine

Cite this

Effect of fluvoxamine on 5-hydroxytryptamine uptake, paroxetine binding sites and ketanserin binding sites in the Japanese monkey brain and platelets, in vivo and in vitro. / Goto, Shinichiro; Egashira, Toru; Wada, Yuji; Takayama, Fusako; Yamanaka, Yasumitsu.

In: Japanese Journal of Pharmacology, Vol. 71, No. 4, 1996, p. 291-298.

Research output: Contribution to journalArticle

@article{cfaa55f395b748d988f0cdd16b38d9e8,
title = "Effect of fluvoxamine on 5-hydroxytryptamine uptake, paroxetine binding sites and ketanserin binding sites in the Japanese monkey brain and platelets, in vivo and in vitro",
abstract = "We investigated the in vitro effects of fluvoxamine on 3H-paroxetine binding and 3H-monoamine uptake in monkey cerebral cortex in comparison with those of other antidepressants. Fluvoxamine selectively inhibited 3H-5-hydroxytryptamine (5-HT) uptake and 3H-paroxetine binding. However, it did not alter 3H-norepinephrine or 3H-dopamine uptake. In addition, we examined the effects of chronic treatment with fluvoxamine (5 mg/kg per day, p.o.) on 5-HT uptake sites that bind 3H-paroxetine and 5-HT2 receptors that bind 3H-ketanserin, in monkey brains and platelets. Chronic treatment with fluvoxamine affected neither the paroxetine binding sites nor the kentanserin binding sites of the brains and platelets. These results suggest that long-term treatment with fluvoxamine does not affect either the 5-HT uptake sites or 5-HT2-receptors of 5-HT neurons in monkey brain in spite of its strong inhibitory effect on 5-HT uptake in vitro.",
keywords = "5-Hydroxytryptamine uptake, Fluvoxamine, Monkey brain, Monkey platelet, Paroxetine binding",
author = "Shinichiro Goto and Toru Egashira and Yuji Wada and Fusako Takayama and Yasumitsu Yamanaka",
year = "1996",
language = "English",
volume = "71",
pages = "291--298",
journal = "Japanese Journal of Pharmacology",
issn = "0021-5198",
publisher = "Japanese Pharmacological Society",
number = "4",

}

TY - JOUR

T1 - Effect of fluvoxamine on 5-hydroxytryptamine uptake, paroxetine binding sites and ketanserin binding sites in the Japanese monkey brain and platelets, in vivo and in vitro

AU - Goto, Shinichiro

AU - Egashira, Toru

AU - Wada, Yuji

AU - Takayama, Fusako

AU - Yamanaka, Yasumitsu

PY - 1996

Y1 - 1996

N2 - We investigated the in vitro effects of fluvoxamine on 3H-paroxetine binding and 3H-monoamine uptake in monkey cerebral cortex in comparison with those of other antidepressants. Fluvoxamine selectively inhibited 3H-5-hydroxytryptamine (5-HT) uptake and 3H-paroxetine binding. However, it did not alter 3H-norepinephrine or 3H-dopamine uptake. In addition, we examined the effects of chronic treatment with fluvoxamine (5 mg/kg per day, p.o.) on 5-HT uptake sites that bind 3H-paroxetine and 5-HT2 receptors that bind 3H-ketanserin, in monkey brains and platelets. Chronic treatment with fluvoxamine affected neither the paroxetine binding sites nor the kentanserin binding sites of the brains and platelets. These results suggest that long-term treatment with fluvoxamine does not affect either the 5-HT uptake sites or 5-HT2-receptors of 5-HT neurons in monkey brain in spite of its strong inhibitory effect on 5-HT uptake in vitro.

AB - We investigated the in vitro effects of fluvoxamine on 3H-paroxetine binding and 3H-monoamine uptake in monkey cerebral cortex in comparison with those of other antidepressants. Fluvoxamine selectively inhibited 3H-5-hydroxytryptamine (5-HT) uptake and 3H-paroxetine binding. However, it did not alter 3H-norepinephrine or 3H-dopamine uptake. In addition, we examined the effects of chronic treatment with fluvoxamine (5 mg/kg per day, p.o.) on 5-HT uptake sites that bind 3H-paroxetine and 5-HT2 receptors that bind 3H-ketanserin, in monkey brains and platelets. Chronic treatment with fluvoxamine affected neither the paroxetine binding sites nor the kentanserin binding sites of the brains and platelets. These results suggest that long-term treatment with fluvoxamine does not affect either the 5-HT uptake sites or 5-HT2-receptors of 5-HT neurons in monkey brain in spite of its strong inhibitory effect on 5-HT uptake in vitro.

KW - 5-Hydroxytryptamine uptake

KW - Fluvoxamine

KW - Monkey brain

KW - Monkey platelet

KW - Paroxetine binding

UR - http://www.scopus.com/inward/record.url?scp=0029843960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029843960&partnerID=8YFLogxK

M3 - Article

C2 - 8886926

AN - SCOPUS:0029843960

VL - 71

SP - 291

EP - 298

JO - Japanese Journal of Pharmacology

JF - Japanese Journal of Pharmacology

SN - 0021-5198

IS - 4

ER -